<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Tetra Bio-pharma Inc. — News on 6ix</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc</link>
<description>Latest news and press releases for Tetra Bio-pharma Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Fri, 10 Feb 2023 23:28:39 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/tetra-bio-pharma-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835c79478dffbe2df11b84a.webp</url>
<title>Tetra Bio-pharma Inc.</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc</link>
</image>
<item>
<title>Tetra Bio-Pharma Announces Listing to OTCPink Market</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-announces-listing-to-otcpink-market</link>
<guid isPermaLink="true">https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-announces-listing-to-otcpink-market</guid>
<pubDate>Fri, 10 Feb 2023 23:28:39 GMT</pubDate>
<description>Tetra Bio-Pharma Announces Listing to OTCPink Market.</description>
</item>
<item>
<title>REDUVO™ Marketing Approval on the Right Path</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc/news/reduvotm-marketing-approval-on-the-right-path</link>
<guid isPermaLink="true">https://6ix.com/company/tetra-bio-pharma-inc/news/reduvotm-marketing-approval-on-the-right-path</guid>
<pubDate>Thu, 22 Dec 2022 12:43:08 GMT</pubDate>
<description>REDUVO™ Marketing Approval on the Right Path.</description>
</item>
<item>
<title>Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-announces-results-of-artificial-intelligence-study-of-ards-003-combined-with-favipiravir</link>
<guid isPermaLink="true">https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-announces-results-of-artificial-intelligence-study-of-ards-003-combined-with-favipiravir</guid>
<pubDate>Tue, 06 Dec 2022 12:01:30 GMT</pubDate>
<description>Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir.</description>
</item>
<item>
<title>Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-provides-update-on-patent-applications-for-novel-therapeutic-ards-003</link>
<guid isPermaLink="true">https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-provides-update-on-patent-applications-for-novel-therapeutic-ards-003</guid>
<pubDate>Tue, 29 Nov 2022 12:01:40 GMT</pubDate>
<description>Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003.</description>
</item>
<item>
<title>Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug Submission</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-provides-update-on-its-reduvotm-new-drug-submission</link>
<guid isPermaLink="true">https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-provides-update-on-its-reduvotm-new-drug-submission</guid>
<pubDate>Fri, 18 Nov 2022 17:24:41 GMT</pubDate>
<description>Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug Submission.</description>
</item>
<item>
<title>Tetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue Ocean</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-inc-announces-second-closing-of-financing-with-alpha-blue-ocean</link>
<guid isPermaLink="true">https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-inc-announces-second-closing-of-financing-with-alpha-blue-ocean</guid>
<pubDate>Thu, 27 Oct 2022 18:00:09 GMT</pubDate>
<description>Tetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue Ocean.</description>
</item>
<item>
<title>Tetra and Prepaire Jointly Apply to BARDA for Funding</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-and-prepaire-jointly-apply-to-barda-for-funding</link>
<guid isPermaLink="true">https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-and-prepaire-jointly-apply-to-barda-for-funding</guid>
<pubDate>Tue, 11 Oct 2022 11:43:43 GMT</pubDate>
<description>Tetra and Prepaire Jointly Apply to BARDA for Funding.</description>
</item>
<item>
<title>Tetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue Ocean</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-inc-announces-revised-terms-and-first-closing-of-financing-with-alpha-blue-ocean</link>
<guid isPermaLink="true">https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-inc-announces-revised-terms-and-first-closing-of-financing-with-alpha-blue-ocean</guid>
<pubDate>Thu, 08 Sep 2022 11:45:44 GMT</pubDate>
<description>Tetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue Ocean.</description>
</item>
<item>
<title>Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 Patients</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-collaborates-with-cellvera-to-develop-a-potential-oral-combination-treatment-for-covid-19-patients</link>
<guid isPermaLink="true">https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-collaborates-with-cellvera-to-develop-a-potential-oral-combination-treatment-for-covid-19-patients</guid>
<pubDate>Tue, 06 Sep 2022 13:15:09 GMT</pubDate>
<description>Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 Patients.</description>
</item>
<item>
<title>Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue Ocean</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-inc-secures-dollar6000000-financing-from-alpha-blue-ocean</link>
<guid isPermaLink="true">https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-inc-secures-dollar6000000-financing-from-alpha-blue-ocean</guid>
<pubDate>Fri, 12 Aug 2022 02:20:47 GMT</pubDate>
<description>Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue Ocean.</description>
</item>
<item>
<title>Tetra Bio-Pharma Announces Positive Preclinical Results of ARDS-003, a Novel Therapeutic for Sepsis and Viral Infections</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-announces-positive-preclinical-results-of-ards-003-a-novel-therapeutic-for-sepsis-and-viral-infections</link>
<guid isPermaLink="true">https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-announces-positive-preclinical-results-of-ards-003-a-novel-therapeutic-for-sepsis-and-viral-infections</guid>
<pubDate>Wed, 10 Aug 2022 10:31:09 GMT</pubDate>
<description>Tetra Bio-Pharma Announces Positive Preclinical Results of ARDS-003, a Novel Therapeutic for Sepsis and Viral Infections.</description>
</item>
<item>
<title>Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc/news/akanda-to-supply-tetra-bio-pharma-with-pharmaceutical-grade-cannabis-for-fda-trials-of-qixleeftm-a-potential-multimillion-dollar-prescription-drug</link>
<guid isPermaLink="true">https://6ix.com/company/tetra-bio-pharma-inc/news/akanda-to-supply-tetra-bio-pharma-with-pharmaceutical-grade-cannabis-for-fda-trials-of-qixleeftm-a-potential-multimillion-dollar-prescription-drug</guid>
<pubDate>Tue, 12 Jul 2022 11:33:08 GMT</pubDate>
<description>Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug.</description>
</item>
<item>
<title>Tetra Bio-Pharma Opens New Subsidiary in Australia and Provides Regulatory Update</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-opens-new-subsidiary-in-australia-and-provides-regulatory-update</link>
<guid isPermaLink="true">https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-opens-new-subsidiary-in-australia-and-provides-regulatory-update</guid>
<pubDate>Mon, 06 Jun 2022 11:35:09 GMT</pubDate>
<description>Tetra Bio-Pharma Opens New Subsidiary in Australia and Provides Regulatory Update.</description>
</item>
<item>
<title>Tetra Bio-Pharma Announces Voting Results of 2022 Annual General and Special Meeting</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-announces-voting-results-of-2022-annual-general-and-special-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-announces-voting-results-of-2022-annual-general-and-special-meeting</guid>
<pubDate>Tue, 31 May 2022 14:39:39 GMT</pubDate>
<description>Tetra Bio-Pharma Announces Voting Results of 2022 Annual General and Special Meeting.</description>
</item>
<item>
<title>Tetra Bio-Pharma Appoints Chief Financial Officer</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-appoints-chief-financial-officer</link>
<guid isPermaLink="true">https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-appoints-chief-financial-officer</guid>
<pubDate>Mon, 30 May 2022 11:45:39 GMT</pubDate>
<description>Tetra Bio-Pharma Appoints Chief Financial Officer.</description>
</item>
<item>
<title>Tetra Bio-Pharma Receives EMA Orphan Drug Designation for a Novel Topical Therapeutic Containing CBD</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-receives-ema-orphan-drug-designation-for-a-novel-topical-therapeutic-containing-cbd</link>
<guid isPermaLink="true">https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-receives-ema-orphan-drug-designation-for-a-novel-topical-therapeutic-containing-cbd</guid>
<pubDate>Wed, 18 May 2022 11:58:09 GMT</pubDate>
<description>Tetra Bio-Pharma Receives EMA Orphan Drug Designation for a Novel Topical Therapeutic Containing CBD.</description>
</item>
<item>
<title>Tetra Bio-Pharma Announces Closing of First Tranche with Cannvalate</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-announces-closing-of-first-tranche-with-cannvalate</link>
<guid isPermaLink="true">https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-announces-closing-of-first-tranche-with-cannvalate</guid>
<pubDate>Tue, 17 May 2022 15:16:11 GMT</pubDate>
<description>Tetra Bio-Pharma Announces Closing of First Tranche with Cannvalate.</description>
</item>
<item>
<title>Tetra Bio-Pharma Announces Licensing Agreement with True North for Patented CBD Technology</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-announces-licensing-agreement-with-true-north-for-patented-cbd-technology</link>
<guid isPermaLink="true">https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-announces-licensing-agreement-with-true-north-for-patented-cbd-technology</guid>
<pubDate>Tue, 10 May 2022 15:00:46 GMT</pubDate>
<description>Tetra Bio-Pharma Announces Licensing Agreement with True North for Patented CBD Technology.</description>
</item>
<item>
<title>Tetra Bio-Pharma and Cannvalate Enter Into Partnership</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-and-cannvalate-enter-into-partnership</link>
<guid isPermaLink="true">https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharma-and-cannvalate-enter-into-partnership</guid>
<pubDate>Thu, 05 May 2022 10:31:38 GMT</pubDate>
<description>Tetra Bio-Pharma and Cannvalate Enter Into Partnership.</description>
</item>
<item>
<title>Tetra Bio-Pharma's QIXLEEF™ on Track After Type C Meeting with U.S. FDA</title>
<link>https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharmas-qixleeftm-on-track-after-type-c-meeting-with-us-fda</link>
<guid isPermaLink="true">https://6ix.com/company/tetra-bio-pharma-inc/news/tetra-bio-pharmas-qixleeftm-on-track-after-type-c-meeting-with-us-fda</guid>
<pubDate>Thu, 17 Mar 2022 10:32:09 GMT</pubDate>
<description>Tetra Bio-Pharma's QIXLEEF™ on Track After Type C Meeting with U.S. FDA.</description>
</item>
</channel>
</rss>